go back

Breast Cancer Gene Activity Recurrence Score

Maryland rates for HCPCS 81519

A laboratory test run on breast tumor tissue already removed at biopsy or surgery, measuring how active a panel of genes is and combining the readings into a single score. The score estimates how likely the cancer is to come back and how much benefit chemotherapy would be expected to add to hormone treatment. It is used to help decide whether chemotherapy is worthwhile.

Rates data updated July 2026.

Facilitymedian $2,951 · 10th–90th $1,622$15,1360%20%40%10th90th$2,951Professionalmedian $3,090 · 10th–90th $1,738$3,9810%20%10th90th$3,090$50.0$200.0$1.0K$5.0K$20.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$15,135.61
Median
$15,135.61
Typical High
$15,135.61
Aetna
Setting
Professional
Modifier
Global
Typical Low
$2,884.03
Median
$3,162.28
Typical High
$3,890.45
CareFirst
Setting
Professional
Modifier
Global
Typical Low
$2,818.38
Median
$2,818.38
Typical High
$3,467.37
Cigna
Setting
Professional
Modifier
Global
Typical Low
$2,041.74
Median
$2,398.83
Typical High
$6,760.83
Kaiser Permanente
Setting
Professional
Modifier
Global
Typical Low
$3,890.45
Median
$4,677.35
Typical High
$5,754.40
United
Setting
Facility
Modifier
Global
Typical Low
$1,621.81
Median
$1,621.81
Typical High
$2,951.21
United
Setting
Professional
Modifier
Global
Typical Low
$1,621.81
Median
$1,862.09
Typical High
$3,388.44
Wellpoint
Setting
Professional
Modifier
Global
Typical Low
$1,949.84
Median
$3,090.30
Typical High
$3,090.30